financing

News

German biotech Tubulis raises €128m for ADC trials

Munich-based antibody-drug conjugate (ADC) specialist Tubulis has completed a sizeable Series B2 financing that shows sustained investor appetite for the ADC category, par

News

Regulus cues up $100m placement on ADPKD drug data

Buoyed by encouraging data for its lead drug for autosomal dominant polycystic kidney disease, Regulus Therapeutics has moved swiftly to file a financing that will give it

News

Boundless Bio files IPO, and other biotech financings

Boundless Bio made a play to become the seventh US biotech to seek a public listing in 2024, ending a brief hiatus in IPO activity after a busy start to the year.

News

RYSE’s $50m digital health fund makes first investment

UK healthcare investor RYSE Asset Management has closed a new fund to support start-ups involved in digital health and care technologies, raising $50 million.

News

RNA therapy firm Avidity files $400m placement

Avidity Biosciences has filed a private placement worth around $400 million, seeking a cash infusion to help advance its pipeline of clinical-stage candidates that combine

News

University of Southampton scientist Prof Ali Tavassoli, who is Curve's chief scientific officer

UK biotech Curve swings £40.5m in Pfizer-backed round

Southampton, UK-based start-up Curve Therapeutics has completed a £40.5 million ($51 million) in Series A financing for its drug discovery platform that enables drug scree

German biotech Tubulis raises €128m for ADC trials

Regulus cues up $100m placement on ADPKD drug data

Boundless Bio files IPO, and other biotech financings

RYSE’s $50m digital health fund makes first investment

RNA therapy firm Avidity files $400m placement

UK biotech Curve swings £40.5m in Pfizer-backed round

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

financing

Editor's Picks